Atrimustine
- Level
- Commodity
- Parent
- 51112500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51112502This classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula C41H47Cl2NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XC0K09B7K4, chemically known as estradiol 3-benzoate 17-glycolate, 4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate but more generally known as atrimustine, which bears US NIH Compound Identifier 53181. European Medicines Agency schedules Atrimustine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05605MIG. The term ATRIMUSTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). ATRIMUSTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule atrimustine under HS 29224995 and SITC 51465. As of Q4 2014, ATRIMUSTINE remains US FDA's Preferred Term for this commodity. Atrimustine bears US NLM identifiers UMLS ID C0105764 and NCI Concept Code C1348. SMILES: CLCCN(C1CCC(CCCC(=O)OCC(=O)OC2C3(C(C4C(CC3)C3C(CC4)CC(OC(=O)C4CCCCC4)CC3)CC2)C)CC1)CCCL.
Same parent
Under 51112500 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51110000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.